Tobi Communications Medicine.2023;[Epub] CrossRef Predictors of HbA1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study Wei Ying Tan, Wynne Hsu, Mong Li Lee, Ngiap Chuan Tan Scientific Reports.2023;[Epub] CrossRef Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon Diabetes & Metabolism Journal.2023
Monitoring, Safety, and When to Adjust Other Medications Patients starting GLP-1 therapy should have baseline blood pressure measurement and regular monitoring (every 24 weeks initially, then monthly)
HRT replaces estrogen, which acts as a natural anti-inflammatory inside joint tissues to stop aches
CTA Explore the potential of BPC-157 and GHK-Cu in tissue repair and recovery with high quality research materials